ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 26 filers reported holding ASCENDIS PHARMA A/S in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $33,137,000 | +2018.7% | 251,900 | +1713.7% | 8.24% | +1472.1% |
| Q1 2020 | $1,564,000 | -85.3% | 13,889 | -84.6% | 0.52% | -81.7% |
| Q1 2019 | $10,631,000 | +370.2% | 90,325 | -19.7% | 2.87% | +84.1% |
| Q3 2016 | $2,261,000 | -15.9% | 112,497 | -44.5% | 1.56% | +13.5% |
| Q2 2016 | $2,687,000 | -22.6% | 202,520 | +8.2% | 1.37% | +8.0% |
| Q1 2016 | $3,473,000 | -33.4% | 187,220 | -34.3% | 1.27% | -45.0% |
| Q4 2015 | $5,217,000 | +9.3% | 284,785 | +5.6% | 2.31% | -29.4% |
| Q3 2015 | $4,775,000 | +33.3% | 269,785 | +33.2% | 3.27% | +85.0% |
| Q2 2015 | $3,581,000 | – | 202,525 | – | 1.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |